Resultados globales: 21 registros encontrados en 0.02 segundos.
Artículos, Encontrados 20 registros
Documentos de investigación, Encontrados 1 registros
Artículos Encontrados 20 registros  1 - 10siguiente  ir al registro:
1.
22 p, 3.7 MB Comparative Analysis of PSA Density and an MRI-Based Predictive Model to Improve the Selection of Candidates for Prostate Biopsy / Morote Robles, Juan (Hospital Universitari Vall d'Hebron) ; Borque-Fernando, Ángel (Hospital Universitario Miguel Servet (Saragossa)) ; Triquell, Marina (Hospital Universitari Vall d'Hebron) ; Celma, Ana (Hospital Universitari Vall d'Hebron) ; Regis, Lucas (Hospital Universitari Vall d'Hebron) ; Mast, Richard (Hospital Universitari Vall d'Hebron) ; de Torres, Inés M. (Hospital Universitari Vall d'Hebron) ; Semidey, María E. (Hospital Universitari Vall d'Hebron) ; Abascal, Jose Maria (Parc de Salut MAR de Barcelona) ; Servian, Pol (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Fàbrega-Santamaria, Anna (Hospital Universitari Vall d'Hebron) ; Planas, Jacques (Hospital Universitari Vall d'Hebron) ; Esteban, Luis M (Universidad de Zaragoza) ; Trilla Herrera, Enrique (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
Magnetic resonance imaging (MRI)-associated prostate-specific antigen density (mPSAD) and MRI predictive models have been proposed for improving the selection of candidates for prostate biopsy among men with suspected prostate cancer (PCa). [...]
2022 - 10.3390/cancers14102374
Cancers, Vol. 14 (may 2022)  
2.
18 p, 1.7 MB Magnetic Resonance Imaging-Based Predictive Models for Clinically Significant Prostate Cancer : A Systematic Review / Triquell, Marina (Hospital Universitari Vall d'Hebron) ; Campistol, Miriam (Hospital Universitari Vall d'Hebron) ; Celma, Ana (Hospital Universitari Vall d'Hebron) ; Regis, Lucas (Hospital Universitari Vall d'Hebron) ; Cuadras, Mercè (Hospital Universitari Vall d'Hebron) ; Planas, Jacques (Hospital Universitari Vall d'Hebron) ; Trilla Herrera, Enrique (Hospital Universitari Vall d'Hebron) ; Morote Robles, Juan (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
Magnetic resonance imaging (MRI) has allowed the early detection of PCa to evolve towards clinically significant PCa (csPCa), decreasing unnecessary prostate biopsies and overdetection of insignificant tumours. [...]
2022 - 10.3390/cancers14194747
Cancers, Vol. 14 (september 2022)  
3.
22 p, 4.7 MB Loss of microRNA-135b Enhances Bone Metastasis in Prostate Cancer and Predicts Aggressiveness in Human Prostate Samples / Olivan, M (Hospital Universitari Vall d'Hebron) ; García, Marta (Institut de Recerca Sant Joan de Déu) ; Suárez, Leticia (Hospital Universitari Vall d'Hebron) ; Guiu, Marc (Institut de Recerca Biomèdica) ; Gros, Laura (Hospital Universitari Vall d'Hebron) ; Méndez Fernández, Olga (Hospital Universitari Vall d'Hebron) ; Rigau, Marina (Hospital Universitari de Bellvitge) ; Reventós, Jaume (Hospital Universitari de Bellvitge) ; Segura, Miguel F. (Hospital Universitari Vall d'Hebron) ; de Torres, Inés (Hospital Universitari Vall d'Hebron) ; Planas, Jacques (Hospital Universitari Vall d'Hebron) ; de la Cruz, Xavier (Hospital Universitari Vall d'Hebron) ; Gomis, Roger R. (Hospital Universitari de Bellvitge) ; Morote Robles, Juan (Hospital Universitari Vall d'Hebron) ; Rodríguez-Barrueco, Ruth (Hospital Universitari de Bellvitge) ; Santamaría, Anna (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
Prostate cancer (PCa) is the most prevalent cancer in males worldwide, and it was the fifth leading cause of cancer mortality in this group in 2020. Near 70% of advanced-stage PCa patients will undergo bone metastasis, suffering pathological complications that severely affect patients' quality of life and probably progress in most cases to lethal PCa. [...]
2021 - 10.3390/cancers13246202
Cancers, Vol. 13 (december 2021)  
4.
14 p, 2.2 MB A Clinically Significant Prostate Cancer Predictive Model Using Digital Rectal Examination Prostate Volume Category to Stratify Initial Prostate Cancer Suspicion and Reduce Magnetic Resonance Imaging Demand / Morote Robles, Juan (Hospital Universitari Vall d'Hebron) ; Borque-Fernando, Ángel (Hospital Universitario Miguel Servet (Saragossa)) ; Triquell, Marina (Hospital Universitari Vall d'Hebron) ; Campistol, Miriam (Hospital Universitari Vall d'Hebron) ; Celma, Ana (Hospital Universitari Vall d'Hebron) ; Regis, Lucas (Hospital Universitari Vall d'Hebron) ; Abascal, Jose Maria (Parc de Salut MAR de Barcelona) ; Servian, Pol (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Planas, Jacques (Hospital Universitari Vall d'Hebron) ; Mendez, Olga (Hospital Universitari Vall d'Hebron) ; Esteban, Luis M (Universidad de Zaragoza) ; Trilla Herrera, Enrique (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
Early detection of PCa (PCa) has evolved towards clinically significant PCa (csPCa) after the spread of pre-biopsy multiparametric magnetic resonance imaging (mpMRI). However, PCa suspicion remains based on prostate-specific antigen (PSA) elevation and/or abnormal digital rectal examination (DRE). [...]
2022 - 10.3390/cancers14205100
Cancers, Vol. 14 (october 2022)  
5.
9 p, 1.7 MB Comparison of Rotterdam and Barcelona Magnetic Resonance Imaging Risk Calculators for Predicting Clinically Significant Prostate Cancer / Morote Robles, Juan (Hospital Universitari Vall d'Hebron) ; Borque-Fernando, Ángel (Hospital Universitario Miguel Servet (Saragossa)) ; Triquell, Marina (Hospital Universitari Vall d'Hebron) ; Campistol, Miriam (Hospital Universitari Vall d'Hebron) ; Servian, Pol (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Abascal, Jose Maria (Parc de Salut MAR de Barcelona) ; Planas, Jacques (Hospital Universitari Vall d'Hebron) ; Méndez Fernández, Olga (Hospital Universitari Vall d'Hebron) ; Esteban, Luis M. (Universidad de Zaragoza) ; Trilla Herrera, Enrique (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
The Barcelona magnetic resonance imaging (MRI)-based risk calculator (BCN MRI-RC) exhibited, in the analysed population, better behaviour than the Rotterdam-MRI risk calculator to improve candidate selection for prostate biopsy for the early detection of clinically significant prostate cancer. [...]
2023 - 10.1016/j.euros.2023.03.013
European Urology Open Science, Vol. 53 (may 2023) , p. 46-54  
6.
3 p, 385.5 KB A risk-organised model for clinically significant prostate cancer early detection / Morote Robles, Juan (Hospital Universitari Vall d'Hebron) ; Borque-Fernando, Ángel (Hospital Universitario Miguel Servet (Saragossa)) ; Triquell, Marina (Hospital Universitari Vall d'Hebron) ; Abascal, Jose Maria (Parc de Salut MAR de Barcelona) ; Servian, Pol (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Planas, Jacques (Hospital Universitari Vall d'Hebron) ; Mendez, Olga (Hospital Universitari Vall d'Hebron) ; Esteban, Luis M. (Universidad de Zaragoza) ; Trilla Herrera, Enrique (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
2023 - 10.1002/bco2.230
BJUI Compass, Vol. 4 (march 2023) , p. 420-422  
7.
11 p, 622.0 KB Definition of Castrate Resistant Prostate Cancer : New Insights / Morote Robles, Juan (Universitat Autònoma de Barcelona. Departament de Cirurgia) ; Aguilar, Adriana (Hospital Universitari Vall d'Hebron) ; Planas, Jacques (Hospital Universitari Vall d'Hebron) ; Trilla Herrera, Enrique (Universitat Autònoma de Barcelona. Departament de Cirurgia)
The term castrate resistant prostate cancer (CRPC) was initially proposed by the Prostate Cancer Working Group 2 in 2008 to define the state of clinical and/or biochemical progression of prostate cancer (PCa) in an environment with very low serum testosterone concentration. [...]
2022 - 10.3390/biomedicines10030689
Biomedicines, Vol. 10 (march 2022)  
8.
13 p, 1.7 MB The Barcelona Predictive Model of Clinically Significant Prostate Cancer / Morote Robles, Juan (Universitat Autònoma de Barcelona. Departament de Cirurgia) ; Borque-Fernando, Ángel (Hospital Universitario Miguel Servet (Saragossa)) ; Triquell, Marina (Universitat Autònoma de Barcelona. Departament de Cirurgia) ; Celma, Ana (Universitat Autònoma de Barcelona. Departament de Cirurgia) ; Regis, Lucas (Universitat Autònoma de Barcelona. Departament de Cirurgia) ; Escobar, Manel (Hospital Universitari Vall d'Hebron) ; Mast, Richard (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; de Torres, Inés (Universitat Autònoma de Barcelona. Departament de Ciències Morfològiques) ; Semidey, María E. (Universitat Autònoma de Barcelona. Departament de Ciències Morfològiques) ; Abascal, Jose Maria (Parc de Salut MAR de Barcelona) ; Solà Belda, Carles (Parc de Salut MAR de Barcelona) ; Servian, Pol (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Salvador Hidalgo, Daniel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Santamaría, Anna (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Planas, Jacques (Hospital Universitari Vall d'Hebron) ; Esteban, Luis M. (Universidad de Zaragoza. Departamento de Matemática Aplicada) ; Trilla Herrera, Enrique (Universitat Autònoma de Barcelona. Departament de Cirurgia)
Magnetic-resonance-imaging-based predictive models (MRI-PMs) improve the MRI prediction of clinically significant prostate cancer (csPCa) in prostate biopsies. Risk calculators (RC) provide easy individual assessment of csPCa likelihood. [...]
2022 - 10.3390/cancers14061589
Cancers, Vol. 14 (march 2022)  
9.
10 p, 1.3 MB Application of One-Step Nucleic Acid Amplification (OSNA) in different cancer entities and usefulness in prostate cancer : a systematic review / Cuadras, Mercè (Hospital Universitari Vall d'Hebron) ; Planas, Jacques (Hospital Universitari Vall d'Hebron) ; Celma, Ana (Hospital Universitari Vall d'Hebron) ; Regis, Lucas (Hospital Universitari Vall d'Hebron) ; de Torres, Inés (Hospital Universitari Vall d'Hebron) ; Semidey, M. Eugenia (Hospital Universitari Vall d'Hebron) ; Trilla, Enrique (Hospital Universitari Vall d'Hebron) ; Morote Robles, Juan (Universitat Autònoma de Barcelona. Departament de Cirurgia) ; Universitat Autònoma de Barcelona
Lymph node (LN) status is a key prognostic factor in the decision-making process of different cancer entities, including prostate cancer (PCa). Sectioning and haematoxylin and eosin (H&E) staining technique remain the gold standard for the evaluation of LN metastases despite some limitations, especially low sensitivity in detecting an accurate tumour burden within the LN, as well as a subjective and time-consuming result. [...]
2022 - 10.1186/s12885-022-09355-0
BMC Cancer, Vol. 22 (april 2022)  
10.
10 p, 555.0 KB The Efficacy of Proclarix to Select Appropriate Candidates for Magnetic Resonance Imaging and Derived Prostate Biopsies in Men with Suspected Prostate Cancer / Morote Robles, Juan (Universitat Autònoma de Barcelona. Departament de Cirurgia) ; Campistol, Miriam (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Celma, Ana (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Regis, Lucas (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; de Torres, Inés (Universitat Autònoma de Barcelona. Departament de Cirurgia) ; Semidey, María E. (Universitat Autònoma de Barcelona. Departament de Cirurgia) ; Roche, Sarai (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Mast, Richard (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Santamaría, Anna (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Planas, Jacques (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Trilla Herrera, Enrique (Universitat Autònoma de Barcelona. Departament de Cirurgia)
To analyze how Proclarix is valuable to appropriately select candidates for multiparametric magnetic resonance imaging (mpMRI) and derived biopsies, among men with suspected prostate cancer (PCa). Proclarix is a new marker computing the clinically significant PCa (csPCa) risk, based on serum thosmbospondin-1, cathepsin D, prostate-specific antigen (PSA) and percent free PSA, in addition to age, that has been developed in men with serum PSA 2 to 10 ng/mL, prostate volume ≥35 mL, and normal digital rectal examination (DRE). [...]
2021 - 10.5534/wjmh.210117
The world journal of men's health, Vol. 40 (december 2021) , p. 270-279  

Artículos : Encontrados 20 registros   1 - 10siguiente  ir al registro:
Documentos de investigación Encontrados 1 registros  
1.
202 p, 953.5 KB Anàlisi de l'impacte clínic dels nivells de testosterona sèrica en pacients amb càncer de pròstata sotmesos a deprivació androgènica / Planas Morín, Jacques ; Morote Robles, Juan, dir. (Universitat Autònoma de Barcelona. Departament de Cirurgia)
INTRODUCCIÓ I OBJECTIUS. L'eficàcia de la castració es mesura analitzant els nivells de testosterona, malgrat que no existeix cap evidència clínica en relació amb el nivell de castració òptim. [...]
INTRODUCTION AND OBJECTIVES: The efficacy of castration is measured by the assessment of serum testosterone however no clinical evidence exists regarding the optimal castration level. The primary objective of this study was to determine the serum testosterone castrate level with clinical relevance in prostate cancer (PCa) patients subjected to androgen deprivation therapy (ADT). [...]

Bellaterra : Universitat Autònoma de Barcelona, 2008  

Vea también: autores con nombres similares
7 Planas, J.
1 Planas, J.G.
1 Planas, Jaques
1 Planas, Joana M.
8 Planas, Jordi
74 Planas, Jordi,
1 Planas, Jordi, 1950-
2 Planas, Josep
4 Planas, Josep V.
1 Planas, José G.
8 Planas, José Manuel
¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.